Patrys Limited
Patrys Limited PAB.AX Peers
See (PAB.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PAB.AX | $0.00 | N/A | 4.11M | N/A | N/A | N/A |
| CSL.AX | $244.03 | +0.93% | 118.16B | 28.74 | $8.49 | +1.74% |
| TLX.AX | $25.35 | -1.52% | 8.57B | 169.00 | $0.15 | N/A |
| MSB.AX | $1.74 | N/A | 2.22B | -12.43 | -$0.14 | N/A |
| NEU.AX | $12.82 | +1.50% | 1.60B | 11.76 | $1.09 | N/A |
| BOT.AX | $0.38 | +1.33% | 742.50M | -19.00 | -$0.02 | N/A |
| OPT.AX | $0.60 | N/A | 738.77M | -1.40 | -$0.43 | N/A |
| CU6.AX | $2.29 | +5.05% | 735.90M | -14.31 | -$0.16 | N/A |
| PYC.AX | $1.22 | +1.25% | 708.66M | -11.05 | -$0.11 | N/A |
| CUV.AX | $10.74 | +1.03% | 538.33M | 13.95 | $0.77 | +0.47% |
Stock Comparison
PAB.AX vs CSL.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, CSL.AX has a market cap of 118.16B. Regarding current trading prices, PAB.AX is priced at $0.00, while CSL.AX trades at $244.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas CSL.AX's P/E ratio is 28.74. In terms of profitability, PAB.AX's ROE is -1.14%, compared to CSL.AX's ROE of +0.15%. Regarding short-term risk, PAB.AX is less volatile compared to CSL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs TLX.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, TLX.AX has a market cap of 8.57B. Regarding current trading prices, PAB.AX is priced at $0.00, while TLX.AX trades at $25.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas TLX.AX's P/E ratio is 169.00. In terms of profitability, PAB.AX's ROE is -1.14%, compared to TLX.AX's ROE of +0.06%. Regarding short-term risk, PAB.AX is less volatile compared to TLX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs MSB.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, MSB.AX has a market cap of 2.22B. Regarding current trading prices, PAB.AX is priced at $0.00, while MSB.AX trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas MSB.AX's P/E ratio is -12.43. In terms of profitability, PAB.AX's ROE is -1.14%, compared to MSB.AX's ROE of -0.22%. Regarding short-term risk, PAB.AX is less volatile compared to MSB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs NEU.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, NEU.AX has a market cap of 1.60B. Regarding current trading prices, PAB.AX is priced at $0.00, while NEU.AX trades at $12.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas NEU.AX's P/E ratio is 11.76. In terms of profitability, PAB.AX's ROE is -1.14%, compared to NEU.AX's ROE of +0.49%. Regarding short-term risk, PAB.AX is less volatile compared to NEU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs BOT.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, BOT.AX has a market cap of 742.50M. Regarding current trading prices, PAB.AX is priced at $0.00, while BOT.AX trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas BOT.AX's P/E ratio is -19.00. In terms of profitability, PAB.AX's ROE is -1.14%, compared to BOT.AX's ROE of -0.39%. Regarding short-term risk, PAB.AX is less volatile compared to BOT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs OPT.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, OPT.AX has a market cap of 738.77M. Regarding current trading prices, PAB.AX is priced at $0.00, while OPT.AX trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas OPT.AX's P/E ratio is -1.40. In terms of profitability, PAB.AX's ROE is -1.14%, compared to OPT.AX's ROE of +5.43%. Regarding short-term risk, PAB.AX is less volatile compared to OPT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs CU6.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, CU6.AX has a market cap of 735.90M. Regarding current trading prices, PAB.AX is priced at $0.00, while CU6.AX trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas CU6.AX's P/E ratio is -14.31. In terms of profitability, PAB.AX's ROE is -1.14%, compared to CU6.AX's ROE of -0.36%. Regarding short-term risk, PAB.AX is less volatile compared to CU6.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs PYC.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, PYC.AX has a market cap of 708.66M. Regarding current trading prices, PAB.AX is priced at $0.00, while PYC.AX trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas PYC.AX's P/E ratio is -11.05. In terms of profitability, PAB.AX's ROE is -1.14%, compared to PYC.AX's ROE of -0.71%. Regarding short-term risk, PAB.AX is less volatile compared to PYC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs CUV.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, CUV.AX has a market cap of 538.33M. Regarding current trading prices, PAB.AX is priced at $0.00, while CUV.AX trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas CUV.AX's P/E ratio is 13.95. In terms of profitability, PAB.AX's ROE is -1.14%, compared to CUV.AX's ROE of +0.18%. Regarding short-term risk, PAB.AX is less volatile compared to CUV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs IMM.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, IMM.AX has a market cap of 430.82M. Regarding current trading prices, PAB.AX is priced at $0.00, while IMM.AX trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas IMM.AX's P/E ratio is -7.37. In terms of profitability, PAB.AX's ROE is -1.14%, compared to IMM.AX's ROE of -0.35%. Regarding short-term risk, PAB.AX is less volatile compared to IMM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs DXB.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, DXB.AX has a market cap of 329.82M. Regarding current trading prices, PAB.AX is priced at $0.00, while DXB.AX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas DXB.AX's P/E ratio is -14.25. In terms of profitability, PAB.AX's ROE is -1.14%, compared to DXB.AX's ROE of -1.84%. Regarding short-term risk, PAB.AX is less volatile compared to DXB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs OCC.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, OCC.AX has a market cap of 304.89M. Regarding current trading prices, PAB.AX is priced at $0.00, while OCC.AX trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas OCC.AX's P/E ratio is -63.00. In terms of profitability, PAB.AX's ROE is -1.14%, compared to OCC.AX's ROE of -0.27%. Regarding short-term risk, PAB.AX is less volatile compared to OCC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs RAC.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, RAC.AX has a market cap of 238.01M. Regarding current trading prices, PAB.AX is priced at $0.00, while RAC.AX trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas RAC.AX's P/E ratio is -27.40. In terms of profitability, PAB.AX's ROE is -1.14%, compared to RAC.AX's ROE of -0.39%. Regarding short-term risk, PAB.AX is less volatile compared to RAC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs IMU.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, IMU.AX has a market cap of 141.87M. Regarding current trading prices, PAB.AX is priced at $0.00, while IMU.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas IMU.AX's P/E ratio is -0.95. In terms of profitability, PAB.AX's ROE is -1.14%, compared to IMU.AX's ROE of -1.42%. Regarding short-term risk, PAB.AX is less volatile compared to IMU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs PAR.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, PAR.AX has a market cap of 122.67M. Regarding current trading prices, PAB.AX is priced at $0.00, while PAR.AX trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas PAR.AX's P/E ratio is -6.30. In terms of profitability, PAB.AX's ROE is -1.14%, compared to PAR.AX's ROE of -0.54%. Regarding short-term risk, PAB.AX is less volatile compared to PAR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs PAA.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, PAA.AX has a market cap of 111.93M. Regarding current trading prices, PAB.AX is priced at $0.00, while PAA.AX trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas PAA.AX's P/E ratio is -11.50. In terms of profitability, PAB.AX's ROE is -1.14%, compared to PAA.AX's ROE of -0.87%. Regarding short-term risk, PAB.AX is less volatile compared to PAA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs AGN.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, AGN.AX has a market cap of 101.19M. Regarding current trading prices, PAB.AX is priced at $0.00, while AGN.AX trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas AGN.AX's P/E ratio is -15.80. In terms of profitability, PAB.AX's ROE is -1.14%, compared to AGN.AX's ROE of -0.39%. Regarding short-term risk, PAB.AX is less volatile compared to AGN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs ALA.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ALA.AX has a market cap of 94.71M. Regarding current trading prices, PAB.AX is priced at $0.00, while ALA.AX trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ALA.AX's P/E ratio is -8.00. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ALA.AX's ROE of -0.55%. Regarding short-term risk, PAB.AX is less volatile compared to ALA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs ATH.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ATH.AX has a market cap of 91.27M. Regarding current trading prices, PAB.AX is priced at $0.00, while ATH.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ATH.AX's P/E ratio is -0.50. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ATH.AX's ROE of -1.83%. Regarding short-term risk, PAB.AX and ATH.AX have similar daily volatility (0.00).
PAB.AX vs BIO.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, BIO.AX has a market cap of 89.92M. Regarding current trading prices, PAB.AX is priced at $0.00, while BIO.AX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas BIO.AX's P/E ratio is -41.00. In terms of profitability, PAB.AX's ROE is -1.14%, compared to BIO.AX's ROE of +0.08%. Regarding short-term risk, PAB.AX is less volatile compared to BIO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs EZZ.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, EZZ.AX has a market cap of 82.08M. Regarding current trading prices, PAB.AX is priced at $0.00, while EZZ.AX trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas EZZ.AX's P/E ratio is 8.29. In terms of profitability, PAB.AX's ROE is -1.14%, compared to EZZ.AX's ROE of +0.40%. Regarding short-term risk, PAB.AX is less volatile compared to EZZ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs RCE.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, RCE.AX has a market cap of 79.80M. Regarding current trading prices, PAB.AX is priced at $0.00, while RCE.AX trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas RCE.AX's P/E ratio is -3.28. In terms of profitability, PAB.AX's ROE is -1.14%, compared to RCE.AX's ROE of +2.47%. Regarding short-term risk, PAB.AX is less volatile compared to RCE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs ACW.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ACW.AX has a market cap of 66.72M. Regarding current trading prices, PAB.AX is priced at $0.00, while ACW.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ACW.AX's P/E ratio is -2.10. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ACW.AX's ROE of -0.44%. Regarding short-term risk, PAB.AX is less volatile compared to ACW.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs PIQ.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, PIQ.AX has a market cap of 56.02M. Regarding current trading prices, PAB.AX is priced at $0.00, while PIQ.AX trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas PIQ.AX's P/E ratio is -6.58. In terms of profitability, PAB.AX's ROE is -1.14%, compared to PIQ.AX's ROE of -0.96%. Regarding short-term risk, PAB.AX is less volatile compared to PIQ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs RAD.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, RAD.AX has a market cap of 51.35M. Regarding current trading prices, PAB.AX is priced at $0.00, while RAD.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas RAD.AX's P/E ratio is -0.37. In terms of profitability, PAB.AX's ROE is -1.14%, compared to RAD.AX's ROE of -1.03%. Regarding short-term risk, PAB.AX is less volatile compared to RAD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs CYP.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, CYP.AX has a market cap of 42.93M. Regarding current trading prices, PAB.AX is priced at $0.00, while CYP.AX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas CYP.AX's P/E ratio is -3.80. In terms of profitability, PAB.AX's ROE is -1.14%, compared to CYP.AX's ROE of -0.95%. Regarding short-term risk, PAB.AX is less volatile compared to CYP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs PTX.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, PTX.AX has a market cap of 38.66M. Regarding current trading prices, PAB.AX is priced at $0.00, while PTX.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas PTX.AX's P/E ratio is -4.80. In terms of profitability, PAB.AX's ROE is -1.14%, compared to PTX.AX's ROE of -0.42%. Regarding short-term risk, PAB.AX is less volatile compared to PTX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs ILA.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ILA.AX has a market cap of 37.85M. Regarding current trading prices, PAB.AX is priced at $0.00, while ILA.AX trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ILA.AX's P/E ratio is -6.00. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ILA.AX's ROE of -1.20%. Regarding short-term risk, PAB.AX and ILA.AX have similar daily volatility (0.00).
PAB.AX vs SPL.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, SPL.AX has a market cap of 37.22M. Regarding current trading prices, PAB.AX is priced at $0.00, while SPL.AX trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas SPL.AX's P/E ratio is -2.97. In terms of profitability, PAB.AX's ROE is -1.14%, compared to SPL.AX's ROE of -0.49%. Regarding short-term risk, PAB.AX is less volatile compared to SPL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs LCT.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, LCT.AX has a market cap of 24.53M. Regarding current trading prices, PAB.AX is priced at $0.00, while LCT.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas LCT.AX's P/E ratio is N/A. In terms of profitability, PAB.AX's ROE is -1.14%, compared to LCT.AX's ROE of -0.54%. Regarding short-term risk, PAB.AX and LCT.AX have similar daily volatility (0.00).
PAB.AX vs ADO.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ADO.AX has a market cap of 24.35M. Regarding current trading prices, PAB.AX is priced at $0.00, while ADO.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ADO.AX's P/E ratio is -0.90. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ADO.AX's ROE of -1.34%. Regarding short-term risk, PAB.AX is less volatile compared to ADO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs NYR.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, NYR.AX has a market cap of 23.14M. Regarding current trading prices, PAB.AX is priced at $0.00, while NYR.AX trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas NYR.AX's P/E ratio is -5.50. In terms of profitability, PAB.AX's ROE is -1.14%, compared to NYR.AX's ROE of -0.73%. Regarding short-term risk, PAB.AX is less volatile compared to NYR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs ATX.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ATX.AX has a market cap of 20.17M. Regarding current trading prices, PAB.AX is priced at $0.00, while ATX.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ATX.AX's P/E ratio is -1.73. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ATX.AX's ROE of -0.51%. Regarding short-term risk, PAB.AX is less volatile compared to ATX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs NOX.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, NOX.AX has a market cap of 19.87M. Regarding current trading prices, PAB.AX is priced at $0.00, while NOX.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas NOX.AX's P/E ratio is -6.80. In terms of profitability, PAB.AX's ROE is -1.14%, compared to NOX.AX's ROE of -0.47%. Regarding short-term risk, PAB.AX and NOX.AX have similar daily volatility (0.00).
PAB.AX vs KZA.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, KZA.AX has a market cap of 18.91M. Regarding current trading prices, PAB.AX is priced at $0.00, while KZA.AX trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas KZA.AX's P/E ratio is -0.73. In terms of profitability, PAB.AX's ROE is -1.14%, compared to KZA.AX's ROE of -1.33%. Regarding short-term risk, PAB.AX is less volatile compared to KZA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs BTC.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, BTC.AX has a market cap of 17.57M. Regarding current trading prices, PAB.AX is priced at $0.00, while BTC.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas BTC.AX's P/E ratio is 5.40. In terms of profitability, PAB.AX's ROE is -1.14%, compared to BTC.AX's ROE of +0.58%. Regarding short-term risk, PAB.AX is less volatile compared to BTC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs NC6.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, NC6.AX has a market cap of 15.96M. Regarding current trading prices, PAB.AX is priced at $0.00, while NC6.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas NC6.AX's P/E ratio is -5.60. In terms of profitability, PAB.AX's ROE is -1.14%, compared to NC6.AX's ROE of +3.42%. Regarding short-term risk, PAB.AX is less volatile compared to NC6.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs AVE.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, AVE.AX has a market cap of 15.87M. Regarding current trading prices, PAB.AX is priced at $0.00, while AVE.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas AVE.AX's P/E ratio is N/A. In terms of profitability, PAB.AX's ROE is -1.14%, compared to AVE.AX's ROE of -0.83%. Regarding short-term risk, PAB.AX is less volatile compared to AVE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs MDC.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, MDC.AX has a market cap of 15.07M. Regarding current trading prices, PAB.AX is priced at $0.00, while MDC.AX trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas MDC.AX's P/E ratio is -0.01. In terms of profitability, PAB.AX's ROE is -1.14%, compared to MDC.AX's ROE of +2.75%. Regarding short-term risk, PAB.AX and MDC.AX have similar daily volatility (0.00).
PAB.AX vs IMC.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, IMC.AX has a market cap of 14.96M. Regarding current trading prices, PAB.AX is priced at $0.00, while IMC.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas IMC.AX's P/E ratio is -2.13. In terms of profitability, PAB.AX's ROE is -1.14%, compared to IMC.AX's ROE of -0.64%. Regarding short-term risk, PAB.AX and IMC.AX have similar daily volatility (0.00).
PAB.AX vs BNO.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, BNO.AX has a market cap of 13.22M. Regarding current trading prices, PAB.AX is priced at $0.00, while BNO.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas BNO.AX's P/E ratio is -0.45. In terms of profitability, PAB.AX's ROE is -1.14%, compared to BNO.AX's ROE of -1.16%. Regarding short-term risk, PAB.AX is less volatile compared to BNO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs TRP.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, TRP.AX has a market cap of 11.79M. Regarding current trading prices, PAB.AX is priced at $0.00, while TRP.AX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas TRP.AX's P/E ratio is -2.79. In terms of profitability, PAB.AX's ROE is -1.14%, compared to TRP.AX's ROE of -0.26%. Regarding short-term risk, PAB.AX and TRP.AX have similar daily volatility (0.00).
PAB.AX vs MEM.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, MEM.AX has a market cap of 9.92M. Regarding current trading prices, PAB.AX is priced at $0.00, while MEM.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas MEM.AX's P/E ratio is N/A. In terms of profitability, PAB.AX's ROE is -1.14%, compared to MEM.AX's ROE of -0.79%. Regarding short-term risk, PAB.AX and MEM.AX have similar daily volatility (0.00).
PAB.AX vs ACR.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ACR.AX has a market cap of 9.78M. Regarding current trading prices, PAB.AX is priced at $0.00, while ACR.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ACR.AX's P/E ratio is -1.20. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ACR.AX's ROE of -1.79%. Regarding short-term risk, PAB.AX and ACR.AX have similar daily volatility (0.00).
PAB.AX vs CHM.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, CHM.AX has a market cap of 9.25M. Regarding current trading prices, PAB.AX is priced at $0.00, while CHM.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas CHM.AX's P/E ratio is -0.25. In terms of profitability, PAB.AX's ROE is -1.14%, compared to CHM.AX's ROE of -4.24%. Regarding short-term risk, PAB.AX is less volatile compared to CHM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs NSB.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, NSB.AX has a market cap of 7.09M. Regarding current trading prices, PAB.AX is priced at $0.00, while NSB.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas NSB.AX's P/E ratio is 4.90. In terms of profitability, PAB.AX's ROE is -1.14%, compared to NSB.AX's ROE of +0.23%. Regarding short-term risk, PAB.AX and NSB.AX have similar daily volatility (0.00).
PAB.AX vs IXC.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, IXC.AX has a market cap of 6.99M. Regarding current trading prices, PAB.AX is priced at $0.00, while IXC.AX trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas IXC.AX's P/E ratio is -4.65. In terms of profitability, PAB.AX's ROE is -1.14%, compared to IXC.AX's ROE of +0.02%. Regarding short-term risk, PAB.AX and IXC.AX have similar daily volatility (0.00).
PAB.AX vs ZLD.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ZLD.AX has a market cap of 5.35M. Regarding current trading prices, PAB.AX is priced at $0.00, while ZLD.AX trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ZLD.AX's P/E ratio is -1.07. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ZLD.AX's ROE of +0.75%. Regarding short-term risk, PAB.AX is less volatile compared to ZLD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs BGT.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, BGT.AX has a market cap of 5.29M. Regarding current trading prices, PAB.AX is priced at $0.00, while BGT.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas BGT.AX's P/E ratio is -2.10. In terms of profitability, PAB.AX's ROE is -1.14%, compared to BGT.AX's ROE of -1.15%. Regarding short-term risk, PAB.AX is less volatile compared to BGT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs BIT.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, BIT.AX has a market cap of 3.98M. Regarding current trading prices, PAB.AX is priced at $0.00, while BIT.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas BIT.AX's P/E ratio is -0.30. In terms of profitability, PAB.AX's ROE is -1.14%, compared to BIT.AX's ROE of -13.17%. Regarding short-term risk, PAB.AX is less volatile compared to BIT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs RGS.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, RGS.AX has a market cap of 3.68M. Regarding current trading prices, PAB.AX is priced at $0.00, while RGS.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas RGS.AX's P/E ratio is -1.20. In terms of profitability, PAB.AX's ROE is -1.14%, compared to RGS.AX's ROE of +4.56%. Regarding short-term risk, PAB.AX is less volatile compared to RGS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs VBS.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, VBS.AX has a market cap of 3.46M. Regarding current trading prices, PAB.AX is priced at $0.00, while VBS.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas VBS.AX's P/E ratio is -1.62. In terms of profitability, PAB.AX's ROE is -1.14%, compared to VBS.AX's ROE of -2.39%. Regarding short-term risk, PAB.AX is less volatile compared to VBS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.
PAB.AX vs 1AD.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, 1AD.AX has a market cap of 3.22M. Regarding current trading prices, PAB.AX is priced at $0.00, while 1AD.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas 1AD.AX's P/E ratio is -0.30. In terms of profitability, PAB.AX's ROE is -1.14%, compared to 1AD.AX's ROE of -4.64%. Regarding short-term risk, PAB.AX and 1AD.AX have similar daily volatility (0.00).
PAB.AX vs HXL.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, HXL.AX has a market cap of 2.17M. Regarding current trading prices, PAB.AX is priced at $0.00, while HXL.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas HXL.AX's P/E ratio is -1.30. In terms of profitability, PAB.AX's ROE is -1.14%, compared to HXL.AX's ROE of -0.53%. Regarding short-term risk, PAB.AX and HXL.AX have similar daily volatility (0.00).
PAB.AX vs EX1.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, EX1.AX has a market cap of 1.93M. Regarding current trading prices, PAB.AX is priced at $0.00, while EX1.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas EX1.AX's P/E ratio is -0.12. In terms of profitability, PAB.AX's ROE is -1.14%, compared to EX1.AX's ROE of -1.61%. Regarding short-term risk, PAB.AX and EX1.AX have similar daily volatility (0.00).
PAB.AX vs ANR.AX Comparison
PAB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAB.AX stands at 4.11M. In comparison, ANR.AX has a market cap of 1.49M. Regarding current trading prices, PAB.AX is priced at $0.00, while ANR.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAB.AX currently has a P/E ratio of N/A, whereas ANR.AX's P/E ratio is -0.70. In terms of profitability, PAB.AX's ROE is -1.14%, compared to ANR.AX's ROE of -1.42%. Regarding short-term risk, PAB.AX is less volatile compared to ANR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PAB.AX.